Ramsay Generale dente (FRA:GD6) Risk Assessment


FRA:GD6 Ramsay Generale de Sante SA FRA:GD6
69 GF Score
Price €10.95
GF Value €21.29
! 8 Warning Signs
View Full Analysis

What is Ramsay Generale dente Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Ramsay Generale dente is: No Data: Cannot be evaluated.

Ramsay Generale dente  (FRA:GD6) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Ramsay Generale dente Risk Assessment Related Terms

FRA:GD6 vs HCA, THC, DVA: Risk Assessment Comparison

For the Medical Care Facilities subindustry, Ramsay Generale dente's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ramsay Generale dente Risk Assessment vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ramsay Generale dente's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Ramsay Generale dente's Risk Assessment falls into.


FRA:GD6
69GF Score
Ramsay Generale de Sante SA FRA:GD6
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ramsay Generale dente (FRA:GD6) Overvalued in 2026?

Based on GuruFocus' analysis, Ramsay Generale dente stock appears to be undervalued. The current stock price of €10.95 is trading 48.6% below its estimated GF Value™ of €21.29.

Key valuation signals for FRA:GD6:

  • Risk Assessment:
  • GF Value™: €21.29 vs. price of €10.95 (48.6% below fair value)
  • GF Score™: 69/100 with 8 warning signs

No single metric tells the full story. See the FRA:GD6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ramsay Generale dente Business Description

Address 39 Rue Mstislav, Rostropovitch, Paris, FRA, 75017
Ramsay Generale de Sante SA operates in the private healthcare sector in France. The company provides a comprehensive range of patient care services in thirteen business segments: Nouvelle Aquitaine, Bourgogne-Franche Comte, Brittany, Centre-Val de Loire, Hauts de France, Normandy, Provence Alpes Cote d'Azur, Ile de France, Auvergne-Rhone Alpes, Occitanie, Italy, Nordics, and Head Office. It generates maximum revenue from the Ile de France segment. The company also specializes in cardiology, heart surgery, digestive surgery, dermatology, urology, ophthalmology, vascular and endovascular surgery.
69GF Score

Get the complete analysis for FRA:GD6

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.95
Price
€21.29
GF Value